These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 34162770)

  • 1. Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders.
    Han YH; Lee K; Saha A; Han J; Choi H; Noh M; Lee YH; Lee MO
    Biomol Ther (Seoul); 2021 Sep; 29(5):455-464. PubMed ID: 34162770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specialized pro-resolving mediator network: an update on production and actions.
    Chiang N; Serhan CN
    Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
    Serhan CN; Libreros S; Nshimiyimana R
    Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.
    Serhan CN
    FASEB J; 2017 Apr; 31(4):1273-1288. PubMed ID: 28087575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.
    Chiang N; Serhan CN
    Mol Aspects Med; 2017 Dec; 58():114-129. PubMed ID: 28336292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the Potential Role of Specialized Pro-Resolving Mediators in Obesity-Associated Metabolic Disorders.
    Kim N; Shin HY
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of special proresolving mediators in pain relief.
    Zhang LY; Jia MR; Sun T
    Rev Neurosci; 2018 Aug; 29(6):645-660. PubMed ID: 29420307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.
    Kwon Y
    Mol Nutr Food Res; 2020 Feb; 64(4):e1900824. PubMed ID: 31797565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery.
    Park J; Langmead CJ; Riddy DM
    ACS Pharmacol Transl Sci; 2020 Feb; 3(1):88-106. PubMed ID: 32259091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation.
    Recchiuti A; Serhan CN
    Front Immunol; 2012; 3():298. PubMed ID: 23093949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-Protein Coupled Receptors Involved in the Resolution of Inflammation: Ligands and Therapeutic Perspectives.
    Mastromarino M; Lacivita E; Colabufo NA; Leopoldo M
    Mini Rev Med Chem; 2020; 20(20):2090-2103. PubMed ID: 32682373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch.
    Ji RR
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():273-293. PubMed ID: 36100219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.
    Fredman G; Serhan CN
    Biochem J; 2011 Jul; 437(2):185-97. PubMed ID: 21711247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.
    Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V
    Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developments of specialized pro-resolving mediators in periodontitis.
    Liu YC
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):94-98. PubMed ID: 33723943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.
    Salazar J; Pirela D; Nava M; Castro A; Angarita L; Parra H; Durán-Agüero S; Rojas-Gómez DM; Galbán N; Añez R; Chacín M; Diaz A; Villasmil N; De Sanctis JB; Bermúdez V
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.
    Serhan CN; Chiang N; Dalli J
    Mol Aspects Med; 2018 Dec; 64():1-17. PubMed ID: 28802833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases.
    Tang S; Wan M; Huang W; Stanton RC; Xu Y
    Mediators Inflamm; 2018; 2018():2380319. PubMed ID: 29674943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose pro-resolving mediators temporally reset the resolution response to microbial inflammation.
    Serhan CN; Chiang N; Nshimiyimana R
    Mol Med; 2024 Sep; 30(1):153. PubMed ID: 39294573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases.
    Spite M; Clària J; Serhan CN
    Cell Metab; 2014 Jan; 19(1):21-36. PubMed ID: 24239568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.